Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany

The recently published S2k-guideline on (allergen-) specific immunotherapy (AIT) provides an excellent overview of the evidence on allergen preparations available for AIT in Germany based on the published efficacy studies. Publications based on the guideline are currently being used by the German as...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Allergo J Int
Autori principali: Brehler, Randolf, Klimek, Ludger, Vogelberg, Christian, Werfel, Thomas, Pfaar, Oliver, Hamelmann, Eckard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Medizin 2016
Soggetti:
Position Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861740/
https://ncbi.nlm.nih.gov/pubmed/27226950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40629-016-0096-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi